MetaCap

Voyager Therapeutics Statistics

NASDAQ: VYGRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.53-0.08 (-4.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Voyager Therapeutics by the numbers

Voyager Therapeutics has a market capitalization of $95.2 million based on 62.23M shares outstanding. With trailing EPS of $-1.74, Voyager Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.8% below its 50-day average and 53.6% below its 200-day average.

Average daily trading volume is 770.24K shares, or about $1.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VYGR valuation vs. peer median

VYGR compared with the median of 8 peer companies
MetricVYGRPeer medianDifference
Market cap$95.21M$96.62M-1%
Avg. volume770.24K1.05M-26%

Peer median across 8 companies: OTLK, IPHA, MOLN, LENZ, ZURA, CRDL, FATE, ARMP.

Valuation

Market cap
$95.21M
Price / sales (latest FY)
2.36
EPS (TTM)
$-1.74

Price and trading

Previous close
1.61
Open
1.57
Day range
1.51 – 1.65
52-week range
1.48 – 5.48
52-week change
-63.40%
Beta
—
Volume
639.24K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
95.21M
Forward Pe
-1.16
Eps
-1.74
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.48
Week52 Low
1.48
Avg Volume
770.24K
Shares Outstanding
62.23M
Ma50
2.21
Ma200
3.30
Earnings Date
Nov 5, 2026
Pct From52w High
-72.08%
Pct From52w Low
3.38%

Related